GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Prolight Diagnostics AB (NGM:PRLD) » Definitions » Equity-to-Asset

Prolight Diagnostics AB (NGM:PRLD) Equity-to-Asset : 0.78 (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Prolight Diagnostics AB Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Prolight Diagnostics AB's Total Stockholders Equity for the quarter that ended in Mar. 2024 was kr124.32 Mil. Prolight Diagnostics AB's Total Assets for the quarter that ended in Mar. 2024 was kr160.02 Mil.

The historical rank and industry rank for Prolight Diagnostics AB's Equity-to-Asset or its related term are showing as below:

NGM:PRLD' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.47   Med: 0.96   Max: 0.99
Current: 0.78

During the past 8 years, the highest Equity to Asset Ratio of Prolight Diagnostics AB was 0.99. The lowest was 0.47. And the median was 0.96.

NGM:PRLD's Equity-to-Asset is ranked better than
70.9% of 866 companies
in the Medical Devices & Instruments industry
Industry Median: 0.64 vs NGM:PRLD: 0.78

Prolight Diagnostics AB Equity-to-Asset Historical Data

The historical data trend for Prolight Diagnostics AB's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prolight Diagnostics AB Equity-to-Asset Chart

Prolight Diagnostics AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial 0.97 0.99 0.98 0.99 0.47

Prolight Diagnostics AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.75 0.74 0.72 0.47 0.78

Competitive Comparison of Prolight Diagnostics AB's Equity-to-Asset

For the Medical Instruments & Supplies subindustry, Prolight Diagnostics AB's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Prolight Diagnostics AB's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Prolight Diagnostics AB's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Prolight Diagnostics AB's Equity-to-Asset falls into.



Prolight Diagnostics AB Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Prolight Diagnostics AB's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=132.992/282.533
=

Prolight Diagnostics AB's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )=Total Stockholders Equity/Total Assets
=124.321/160.016
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Prolight Diagnostics AB  (NGM:PRLD) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Prolight Diagnostics AB Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Prolight Diagnostics AB's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Prolight Diagnostics AB (NGM:PRLD) Business Description

Traded in Other Exchanges
N/A
Address
Magistratsvagen 10, Lund, SWE, 223 43
Prolight Diagnostics AB is developing with technology partners near-patient test system based on the patented technology, for use in so-called Point of Care Testing (POCT). The company uses technology such as Mico ELISA and Flex membrane and PLD Micro Flex.